<?xml version='1.0' encoding='UTF-8'?>
<search_results><query id="7236">lomustine</query><engine status="OK" timestamp="2014-04-20 17:01:56" name="MS Academic" id="FW14-e010"/><snippets><snippet id="FW14-e010-7236-01"><link cache="FW14-topics-docs/e010/7236_01.html" timestamp="2014-04-20 17:01:57">http://academic.research.microsoft.com/Publication/14287884/adjuvant-procarbazine-lomustine-and-vincristine-improves-progression-free-survival-but-not</link><title>Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial</title><description>* Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial (Citations: 77)

Martin J. van den Bent, Antoine F. Carpentier, Alba A. Brandes, Marc Sanson, Martin J. B. Taphoorn, Hans J. J. A. Bernsen, Marc Frenay, Cees C. Tijssen, Laslo Sipos, Hanny Haaxma-Reiche, Johannes M. Kros, Mathilde C. M. van Kouwenhovenhttp://academic.research.microsoft.com/io.ashx?type=5&amp;id=14287884&amp;selfId1=-1&amp;selfId2=-1&amp;maxNumber=12&amp;query=lomustine

...controlled trial, whether adjuvant procarbazine, lomustine, and vincristine (pcv) chemotherapy improves...

Published in 2006.</description></snippet><snippet id="FW14-e010-7236-02"><link cache="FW14-topics-docs/e010/7236_02.html" timestamp="2014-04-20 17:02:37">http://academic.research.microsoft.com/Publication/39082591/procarbazine-lomustine-and-vincristine-pcv-chemotherapy-for-grade-iii-and-grade-iv</link><title>Procarbazine, lomustine, and vincristine (PCV) chemotherapy for Grade III and Grade IV oligoastrocytomas</title><description>* Procarbazine, lomustine, and vincristine (PCV) chemotherapy for Grade III and Grade IV oligoastrocytomas (Citations: 59)

Lyndon Kim, Fred H. Hochberg, Allan F. Thornton, Griffith R. Harsh, Heena Patel, Dianne Finkelstein, David N. Louis

Journal: Journal of Neurosurgery - JNS , vol. 85, no. 4, pp. 602-607, 1996</description></snippet><snippet id="FW14-e010-7236-03"><link cache="FW14-topics-docs/e010/7236_03.html" timestamp="2014-04-20 17:05:54">http://academic.research.microsoft.com/Publication/30327680/radiation-therapy-and-bromodeoxyuridine-chemotherapy-followed-by-procarbazine-lomustine-and</link><title>Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas</title><description>* Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas (Citations: 43)

Victor A. Levin, Michael R. Prados, William M. Wara, Richard L. Davis, Philip H. Gutin, Theodore L. Phillips, Kathleen Lamborn, Charles B. Wilson

...following radiotherapy, patients received procarbazine, lomustine (ccnu), and vincristine (pcv) for...

Journal: International Journal of Radiation Oncology Biology Physics - INT J RADIAT ONCOL BIOL PHYS , vol. 32, no. 1, pp. 75-83, 1995</description></snippet><snippet id="FW14-e010-7236-04"><link cache="FW14-topics-docs/e010/7236_04.html" timestamp="2014-04-20 17:08:41">http://academic.research.microsoft.com/Publication/30685282/phase-ii-trial-of-procarbazine-lomustine-and-vincristine-as-initial-therapy-for-patients-with</link><title>Phase II Trial of Procarbazine, Lomustine, and Vincristine as Initial Therapy for Patients With Low-Grade Oligodendroglioma or Oligoastrocytoma: Efficacy and Associations With Chromosomal Abnormalities</title><description>* Phase II Trial of Procarbazine, Lomustine, and Vincristine as Initial Therapy for Patients With Low-Grade Oligodendroglioma or Oligoastrocytoma: Efficacy and Associations With Chromosomal Abnormalities (Citations: 71)

J. C. Buckner

Journal: Journal of Clinical Oncology - J CLIN ONCOL , vol. 21, no. 2, pp. 251-255, 2003</description></snippet><snippet id="FW14-e010-7236-05"><link cache="FW14-topics-docs/e010/7236_05.html" timestamp="2014-04-20 17:12:37">http://academic.research.microsoft.com/Publication/43952170/lomustine-ccnu-for-the-treatment-of-resistant-lymphoma-in-dogs</link><title>Lomustine (CCNU) for the Treatment of Resistant Lymphoma in Dogs</title><description>* Lomustine (CCNU) for the Treatment of Resistant Lymphoma in Dogs (Citations: 39)

Antony S. Moore, Cheryl A. London, Carrie A. Wood, Laurel E. Williams, Susan M. Cotter, Deborah A. L’Heureux, Angela E. Frimberger

Journal: Journal of Veterinary Internal Medicine - J VET INTERN MED , vol. 13, no. 5, 1999</description></snippet><snippet id="FW14-e010-7236-06"><link cache="FW14-topics-docs/e010/7236_06.html" timestamp="2014-04-20 17:14:16">http://academic.research.microsoft.com/Publication/30751377/adjuvant-procarbazine-lomustine-and-vincristine-improves-progression-free-survival-but-not</link><title>Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial</title><description>* Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial (Citations: 62)

M. J. van den Bent

Journal: Journal of Clinical Oncology - J CLIN ONCOL , vol. 24, no. 18, pp. 2715-2722, 2006</description></snippet><snippet id="FW14-e010-7236-07"><link cache="FW14-topics-docs/e010/7236_07.html" timestamp="2014-04-20 17:15:12">http://academic.research.microsoft.com/Publication/43952202/treatment-of-canine-mast-cell-tumors-with-ccnu-lomustine</link><title>Treatment of Canine Mast Cell Tumors with CCNU (Lomustine)</title><description>* Treatment of Canine Mast Cell Tumors with CCNU (Lomustine) (Citations: 39)

Kenneth M. Rassnick, Antony S. Moore, Laurel E. Williams, Cheryl A. London, Peter P. Kintzer, Stephen J. Engler, Susan M. Cotter

Journal: Journal of Veterinary Internal Medicine - J VET INTERN MED , vol. 13, no. 6, 1999</description></snippet><snippet id="FW14-e010-7236-08"><link cache="FW14-topics-docs/e010/7236_08.html" timestamp="2014-04-20 17:18:14">http://academic.research.microsoft.com/Publication/11123311/second-line-chemotherapy-with-temozolomide-in-recurrent-oligodendroglioma-after-pcv-procarbazine</link><title>Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972</title><description>* Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972 (Citations: 57)

Bent van den M. J, O. Chinot, W. Boogerd, J. Bravo Marques, M. J. B. Taphoorn, J. M. Kros, Rijt van der C. C. D, C. J. Vecht, N. De Beule, B. Baron

...pcv combination chemotherapy with procarbazine, lomustine (ccnu) and vincristine. temozolomide (tmz...

Journal: Annals of Oncology - ANN ONCOL , vol. 14, no. 4, pp. 599-602, 2003</description></snippet><snippet id="FW14-e010-7236-09"><link cache="FW14-topics-docs/e010/7236_09.html" timestamp="2014-04-20 17:21:13">http://academic.research.microsoft.com/Publication/30481082/a-randomized-study-of-chemotherapy-with-procarbazine-vincristine-and-lomustine-with-and-without</link><title>A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4</title><description>* A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4 (Citations: 27)

Magnhild Sandberg-Wollheim, Kjeld Hougaard, Per Malmström, Lars-GÖRan Strömblad, Leif G. Salford, Harald Anderson, Stig Borgström, Arne Brun, Sten Cronqvist

Journal: Cancer , vol. 68, no. 1, pp. 22-29, 1991</description></snippet><snippet id="FW14-e010-7236-10"><link cache="FW14-topics-docs/e010/7236_10.html" timestamp="2014-04-20 17:24:05">http://academic.research.microsoft.com/Publication/28119661/chemotherapy-for-bronchogenic-carcinoma-methotrexate-doxorubicin-cyclophosphamide-and-lomustine</link><title>Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine</title><description>* Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine (Citations: 12)

P. A. Chahinian

Journal: Jama-journal of The American Medical Association - JAMA-J AM MED ASSN , vol. 237, no. 22, pp. 2392-2396, 1977</description></snippet></snippets></search_results>